Skip to main content
View Cart

Journals in Hematology

  • Atherosclerosis

    • ISSN: 0021-9150
    Cardiovascular disease (CVD) causes one third of all deaths worldwide and is a major threat to global health. Atherosclerosis aims to provide a comprehensive platform for researchers, clinicians and healthcare professionals to share the latest findings and advances in the field of atherosclerosis. Atherosclerosis covers a wide range of topics, including:Pathophysi... and Mechanisms: We explore the intricate cellular and molecular processes involved in atherogenesis, from the initial formation of fatty streaks to the development of complex plaques. We also welcome studies on cardiac biology and disease.Risk Factors: We consider manuscripts that examine both traditional and emerging risk factors for atherosclerosis, such as dyslipidaemia, hypertension, diabetes mellitus, thrombosis and genetic predisposition.Preve... of CVD: Since prevention will become a major focus in the future (see e.g. the European Cardiovascular Health Plan), an important focus will be on preventive strategies, including lifestyle modifications and pharmacological interventions.Diagno... Techniques: We features articles on cutting-edge diagnostic techniques, ranging from invasive procedures such as selective coronary arteriography to non-invasive techniques such as blood biomarkers.Treatment Approaches: Atherosclerosis covers the latest developments in the treatment of atherosclerosis, including lipid-lowering therapies, anti-inflammatory treatments and novel targeted approaches aimed at modifying disease progression and improving clinical outcomes.Translation... Research: We bridges the gap between basic science and clinical practice by highlighting translational studies that bring laboratory findings closer to practical applications in patient care.By fostering collaboration and knowledge exchange between researchers and clinicians, Atherosclerosis aims to accelerate progress in the understanding, prevention and treatment of atherosclerosis, ultimately improving the lives of the millions of people affected by this pervasive disease.
    Subscriptions

  • Radiotherapy & Oncology

    • ISSN: 0167-8140
    Journal of the European Society for Radiotherapy and Oncology and affiliated to the Canadian Association of Radiation Oncology.Radiotherap... and Oncology, also known as the Green journal, aims at driving innovation in radiation oncology. It publishes high impact articles describing original research as well as review articles. It covers all areas of interest relating to clinical radiotherapy and oncology, medical physics, radiation biology, as well as other areas relevant to the radiation oncology community such as education, health policy, environmental and societal sustainability or health economics. The journal has a particular interest in prospective clinical trials or large population-based database analyses. It also looks to publish works related to: clinical radiotherapy and brachytherapy, combined modality treatment (for example with chemotherapy, surgery and immunology), particle therapy, translational and experimental radiotherapy and radiation biology, medical physics, imaging, dosimetry, and radiation therapy planning, data science and artificial intelligence research relevant to radiotherapy.ESTRO members can access Radiotherapy and Oncology online via the members-only section of the ESTRO website.
    Subscriptions

  • Seminars in Oncology

    • ISSN: 0093-7754
    Seminars in Oncology brings you current, authoritative, and practical articles on advances in the etiology, diagnosis and management of cancer. The journal is dedicated to providing both the basic knowledge needed to better understand cancer-related subjects as well as evidence-based perspectives from leaders in the field. Seminars in Oncology also seeks to be a venue for sharing diverse viewpoints, including innovative and unconventional ideas that might be considered "outside the box". We encourage a healthy, constructive and respectful exchange of opinions and welcome your insights as well as suggestions for topics worthy of coverage. By deepening readers understand of the basic biology and therapy of cancer through expert insights, and by fostering an open exchange of ideas, Seminars in Oncology aims to advance the science and practice of cancer care.
    Subscriptions

  • Medical Hypotheses

    • ISSN: 0306-9877
    Medical Hypotheses is a forum for ideas in medicine and related biomedical sciences. It will publish interesting and important theoretical papers that foster the diversity and debate upon which the scientific process thrives. The Aims and Scope of Medical Hypotheses are no different now from what was proposed by the founder of the journal, the late Dr David Horrobin. In his introduction to the first issue of the Journal, he asks 'what sorts of papers will be published in Medical Hypotheses? and goes on to answer 'Medical Hypotheses will publish papers which describe theories, ideas which have a great deal of observational support and some hypotheses where experimental support is yet fragmentary'. (David F. Horrobin, Ideas in biomedical science: Reasons for the foundation of medical hypotheses, Medical Hypotheses, Volume 2, Issue 1, 1976, Pages 29-30). Medical Hypotheses was therefore launched, and still exists today, to give novel, radical new ideas and speculations in medicine open-minded consideration, opening the field to radical hypotheses which would be rejected by most conventional journals. Papers in Medical Hypotheses take a standard scientific form in terms of style, structure and referencing. The journal therefore constitutes a bridge between cutting-edge theory and the mainstream of medical and scientific communication, which ideas must eventually enter if they are to be critiqued and tested against observations.Submitt... manuscripts will be reviewed by the Editor and external reviewers to ensure their scientific merit. All reviewers will be fully aware of the Aims and Scope of the Journal and will be judging the premise, originality and plausibility of the hypotheses submitted. The journal publishes 12 issues a year, the publication frequency is monthly.Abstracting/... Medical Hypotheses is indexed and abstracted in: ADONIS, BIOSIS, Chemical Abstracts, Elsevier BIOBASE/Current Contents/Life Sciences, EMBASE Excerpta Medica, Index Medicus, Medical Documentation Service, Reference Update, Research Alert, Science Citation Index, SciSearch UMI (Microfilm), Russian Academy of Science.
    Subscriptions

  • Current Problems in Cancer

    • ISSN: 0147-0272
    Current Problems in Cancer seeks to promote and disseminate innovative, transformative, and impactful data on patient-oriented cancer research and clinical care. Specifically, the journal's scope is focused on reporting the results of well-designed cancer studies that influence/alter practice or identify new directions in translational and clinical cancer research. These studies can include novel therapeutic approaches, new strategies for early diagnosis, cancer clinical trials, and supportive care, among others. Pre-clinical studies are discouraged. The journal's format also allows, on occasion, for a multi-faceted overview of a single topic via a curated selection of review articles, while also offering articles that present dynamic material that influences the oncology field.Original case reports featuring prevention, diagnosis and treatment of cancer, supportive care, quality of life and rehabilitation can be submitted to the journal's open access companion title, Current Problems in Cancer: Case Reports.(CPCCR). Any case reports submitted to Current Problems in Cancer (CPC) will be considered for publication in either CPC or CPCCR.
    Subscriptions

  • Cancer Treatment Reviews

    • ISSN: 0305-7372
    Cancer Treatment Reviews is an international journal that provides state of the art, authoritative review articles to the clinician and researcher to keep them abreast of modern concepts and the latest developments in cancer treatment research.Journal of Cancer Treatment Reviews' Inclusion and Diversity PledgeThis journal pledges to maintain diversity on the editorial team. This sits within Elsevier's broader ongoing inclusion & diversity efforts. Equity and inclusion in publishing is critically important for scientific excellence and innovation. We believe passionately in the power of an inclusive publishing environment, not only to do what is right, but to enrich, strengthen and advance us all.
    Subscriptions

  • European Journal of Oncology Nursing

    • ISSN: 1462-3889
    The European Journal of Oncology Nursing is an international journal which publishes research of direct relevance to patient care, nurse education, management and policy development. EJON is proud to be the official journal of the European Oncology Nursing Society.The journal publishes the following types of papers: • Original research articles • Review articles
    Subscriptions

  • Journal of Thrombosis and Haemostasis

    • ISSN: 1538-7836
    The Journal of Thrombosis and Haemostasis (JTH) is the official journal of the International Society on Thrombosis and Haemostasis. The mission of JTH is to advance science related to the important medical problems of thrombosis, bleeding disorders and vascular biology through the diffusion and exchange of information and ideas within the international research community. The Journal publishes high quality, original research reports, state of the art reviews, brief reports, case reports, invited commentaries on publications in the Journal, forum articles, correspondence and announcements. Editors invite both fundamental and clinical contributions.These include basic manuscripts on blood coagulation and fibrinolysis, proteins and reactions, blood platelets, and the interaction of all these components with other biological systems such as, but not limited to, the vessel wall, blood cells, and invading organisms. Clinical manuscripts can cover a wide variety of topics including venous thrombosis and arterial disease, plus hemophilia and other bleeding disorders, as well as platelet diseases. The subject area of clinical manuscripts can range from etiology to diagnostics, prognosis, prevention, and treatment.
    Subscriptions

  • Blood

    • ISSN: 0006-4971
    Blood, the flagship journal of the American Society of Hematology, published online and in print, provides an international forum for the publication of original articles describing basic laboratory, translational, and clinical investigations in hematology. Acceptance of manuscripts is based on the originality and importance of the observations or investigations, the quality of the work and validity of the evidence, the clarity of presentation, and the relevance to our readership and field. All articles are expected to be concise, well-organized and clearly written. Authors submit a manuscript with the understanding that the manuscript (or its essential substance) has not been published other than as an abstract in any language or format and is not currently submitted elsewhere for print or electronic publication.Primary research articles will be published under the following scientific categories: Clinical Trials and Observations; Gene Therapy; Hematopoiesis and Stem Cells; Immunobiology and Immunotherapy; Myeloid Neoplasia; Lymphoid Neoplasia; Phagocytes, Granulocytes and Myelopoiesis; Platelets and Thrombopoiesis; Red Cells, Iron and Erythropoiesis; Thrombosis and Hemostasis; Transfusion Medicine; Transplantation; and Vascular Biology. Papers can be listed under more than one category as appropriate. Authors are invited to submit a presubmission inquiry if they are uncertain whether their work falls within the general scope of the journal.Blood has formulated more precise scopes for immunobiology and immunotherapy, vascular biology, HIV/HTLV, and clinical trial submissions. The journal is very interested in submissions as reflected in the definitions linked below.Immunobiology and Immunotherapy scopeVascular Biology scopeHIV/HTLV scopeClinical Trials scopeBlood welcomes submission of manuscripts reporting on clinical trials whether phase 1, 2, 3 or 4. Reports should include a full description of the study design, patient population, methodology and conduct, and statistical plan.Immunobiology and Immunotherapy encompass a wide spectrum of research, but Blood can accommodate only papers that have clear and important implications for hematology. Preference is given to papers focusing on human immunobiology, immunotherapy, and immune pharmacology approaches in the human setting and those with significant implications for understanding of normal or malignant hematologic processes. Papers on tumor immunology, tumor vaccines and cancer immunotherapy development may be appropriate if the target cells or antigens are relevant to hematologic malignancies, but generally Blood cannot accommodate tumor immunology papers focusing solely on non-hematologic tumor types.Papers investigating autoimmunity and utilizing non-hematologic models are not within the scope of Blood.Vascular biology papers that focus primarily on atherosclerosis are outside the scope of Blood and instead should be considered for alternative journals.Papers felt to be outside the scope of Blood will be returned to the author without full peer review.
    Subscriptions

  • Seminars in Radiation Oncology

    • ISSN: 1053-4296
    Each issue of Seminars in Radiation Oncology is compiled by a guest editor to address a specific topic in the specialty, presenting definitive information on areas of rapid change and development. A significant number of articles report new scientific information. Topics covered include tumor biology, diagnosis, medical and surgical management of the patient, and new technologies.
    Subscriptions